Haleon (HLN) Retained Earnings (2021 - 2026)
Haleon's (HLN) quarterly Retained Earnings came in at -$15.3 billion in Q2 2026, up 0.88% on a QoQ basis from -$15.4 billion in Q4 2025.
Haleon (HLN) Retained Earnings (2021 - 2026) Analysis & Trends
Haleon (HLN) has 6 years of Retained Earnings data on file, last reported at -$15.3 billion in Q2 2026.
- Quarterly Retained Earnings changed N/A year-over-year to -$15.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$15.3 billion (changed N/A YoY) and the FY2025 annual result came in at -$15.3 billion, down 143.93% from the prior year.
- Retained Earnings rose to -$15.3 billion in Q2 2026, from -$15.4 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $35.0 billion in Q4 2024 to a low of -$15.4 billion in Q4 2025.
- A 5-year average of -$8.4 billion and a median of -$14.6 billion in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings jumped 341.32% — and 2025, when it plunged 144.06%.
- Tracing HLN's Retained Earnings over 5 years: stood at -$13.7 billion in 2022, then dropped by 5.82% to -$14.5 billion in 2023, then jumped by 341.32% to $35.0 billion in 2024, then sank by 144.06% to -$15.4 billion in 2025, then rose by 0.88% to -$15.3 billion in 2026.
- The last three Retained Earnings figures came in at -$15.3 billion (Q2 2026), -$15.4 billion (Q4 2025), and $35.0 billion (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 3.75 Bn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | -800.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.29 Bn |
| Dec 31, 2025 | -15.42 Bn |
| Dec 31, 2024 | 35.00 Bn |
| Jun 30, 2024 | -13.91 Bn |
| Dec 31, 2023 | -14.51 Bn |
| Jun 30, 2023 | -14.62 Bn |
| Dec 31, 2022 | -13.71 Bn |
| Jun 30, 2022 | -14.74 Bn |
| Dec 31, 2021 | -15.69 Bn |